India, USA: Dr. Reddy’s Laboratories Ltd. On Tuesday announced the re-launch of over-the-counter (OTC) Famotidine tablets USP, 10 mg, and 20 mg, The tablet is an equivalent of Pepcid AC®, in the U.S. market, as approved by the U.S. Food and Drug Administration (USFDA).
The release said, The (OTC) Famotidine tablets USP, 10 mg and 20 mg, prevents and relieves heartburn associated with acid indigestion and sour stomach due to eating or drinking certain food and beverages.
Also read: Zydus Cadila gets tentative USFDA nod for Tofacitinib ER tablets
The Tablets are available in multiple pack sizes for providing consumers a variety of options.
“We are pleased to continue to expand our OTC Antacid portfolio for our customers and consumers,” said Marc Kikuchi, CEO, North America Generics, Dr. Reddy’s Laboratories.
The Health Master is now on Telegram. For latest update on health and Pharmaceuticals, subscribe to The Health Master on Telegram.
